Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (161-170 of 625) with videos related to

Pageof 63
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusionHiroaki Kitade, Masaru Kawai, Omer Rutgeerts, et al.
Diabetes Care|March 29, 2002
Sexual dysfunction in women with type 1 diabetes: a controlled studyPaul Enzlin, Chantal Mathieu, Annick Van den Bruel, et al.
Cell Transplantation|September 9, 2014
Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct CellsLei Ding, Yves Heremans, Daniel Pipeleers, et al.
Diabetes/Metabolism Research and Reviews|October 7, 2006
Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patientsVolkert A L Huurman, Katelijn Decochez, Chantal Mathieu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 19, 2015
Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort StudyMarc Claesen, Pieter Gillard, Frank De Smet, et al.
Diabetes, Obesity & Metabolism|December 12, 2025
Efficacy and hypoglycaemia outcomes of once-weekly insulin icodec versus once-daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1-5Alice Y Y Cheng, Gayathri Anil, Luis Canani, et al.
Current Medical Research and Opinion|September 17, 2015
Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trialsLawrence Blonde, Vincent Woo, Chantal Mathieu, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2026
Country-level implementation of Europe's Safe Hearts Plan for cardiovascular healthStefano Del Prato, Francesco Giorgino, Bart Torbeyns, et al.
Diabetology & Metabolic Syndrome|June 16, 2021
Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY studySérgio Vencio, Juan P Manosalva, Chantal Mathieu, et al.
Journal of Diabetes and Its Complications|March 30, 2013
Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetesKris Doggen, Frank Nobels, André J Scheen, et al.
Pageof 63

Showing results (161-170 of 625) with videos related to

Sort By:
Pageof 63
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusionHiroaki Kitade, Masaru Kawai, Omer Rutgeerts, et al.
Diabetes Care|March 29, 2002
Sexual dysfunction in women with type 1 diabetes: a controlled studyPaul Enzlin, Chantal Mathieu, Annick Van den Bruel, et al.
Cell Transplantation|September 9, 2014
Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct CellsLei Ding, Yves Heremans, Daniel Pipeleers, et al.
Diabetes/Metabolism Research and Reviews|October 7, 2006
Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patientsVolkert A L Huurman, Katelijn Decochez, Chantal Mathieu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 19, 2015
Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort StudyMarc Claesen, Pieter Gillard, Frank De Smet, et al.
Diabetes, Obesity & Metabolism|December 12, 2025
Efficacy and hypoglycaemia outcomes of once-weekly insulin icodec versus once-daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1-5Alice Y Y Cheng, Gayathri Anil, Luis Canani, et al.
Current Medical Research and Opinion|September 17, 2015
Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trialsLawrence Blonde, Vincent Woo, Chantal Mathieu, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2026
Country-level implementation of Europe's Safe Hearts Plan for cardiovascular healthStefano Del Prato, Francesco Giorgino, Bart Torbeyns, et al.
Diabetology & Metabolic Syndrome|June 16, 2021
Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY studySérgio Vencio, Juan P Manosalva, Chantal Mathieu, et al.
Journal of Diabetes and Its Complications|March 30, 2013
Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetesKris Doggen, Frank Nobels, André J Scheen, et al.
Pageof 63